Engineering a Tumor-Selective Prodrug T Cell Engager Bispecific Antibody for Safer Immunotherapy

Engineering a Tumor-Selective Prodrug T Cell Engager Bispecific Antibody for Safer Immunotherapy Descriptor: Fab Heavy Chain, Fab Light Chain, PCA-ASP-GLY-ASN-GLU-GLU-MET Authors: Antonysamy, S, Demarest, S, Froning, K, Hickey, M.H, Kuhlman, B, McCue, A.C. Deposit date: 2024-02-06 Release date: 2024-07-24 Last modified: 2024-10-23 Method: X-RAY DIFFRACTION (1.7 Å) Cite: Engineering a tumor-selective prodrug T-cell engager bispecific antibody for safer immunotherapy. Mabs, 16, 2024开发用于更安全免疫治疗的肿瘤选择性前药T细胞衔接双特异性抗体 描述：Fab重链（Fab Heavy Chain）、Fab轻链（Fab Light Chain）、PCA-ASP-GLY-ASN-GLU-GLU-MET 作者：Antonysamy S、Demarest S、Froning K、Hickey M.H、Kuhlman B、McCue A.C. 提交日期：2024-02-06 发布日期：2024-07-24 最后修改日期：2024-10-23 方法：X射线衍射（X-RAY DIFFRACTION），分辨率1.7埃（Å） 引用文献：用于更安全免疫治疗的肿瘤选择性前药T细胞衔接双特异性抗体. 《Mabs》, 16, 2024